Search Results 41-50 of 17087 for amyloidosis
Cardiac amyloidosis occurs when a protein byproduct called amyloid builds up in the heart muscle. This inhibits the hearts ability to pump blood in is sometimes ...
The purpose of this study is to evaluate vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. Participation eligibility. Participant ...
The purpose of this study is to evaluate different heart imaging techniques to detect amyloidosis involving the heart. We are doing this research study to ...
A Study to Evaluate the Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure Patients with Preserved Ejection Fraction in Southeastern Minnesota.
Amyloidosis (am-uh-loi-DO-sis) is a rare disease that occurs when a protein called amyloid builds up in organs. This amyloid buildup can ...
Amyloidosis occurs when a substance called amyloid builds up in the organs. ... Severe amyloidosis can lead to life-threatening organ failure. While ...
Amyloid is an abnormal protein usually produced by cells in the bone marrow that can be deposited in any tissue or organ. Amyloidosis can affect different ...
Blood-based Biomarkers for Early Disease Detection in Cardiac Amyloidosis · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
... amyloidosis to determine feasibility of multi-organ MRE technique, and to perform multi-organ MRE in subjects with AL amyloidosis pre- and post-stem cell ...
The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR). Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.